個人經歷
1998年畢業於白求恩醫科大學（吉林大學白求恩醫學院）。
2008年畢業於日本國立Niigata University（新潟大學）醫學部，獲得日本國醫學博士學位。
2008年-2009年任日本國立Niigata University腦研究所研究機關研究員、日本醫學博士後。
2009年-2011年為中南大學湘雅二醫院精神衛生研究所 精神病與精神衛生學博士後。
2011年10月起任廣州市腦科醫院精神分裂症科研方向學術帶頭人，廣州市腦科醫院成人精神科學術帶頭人，成人精神科副主任。
主要成就
參與編寫國家級繼續教育教材《精神病學新進展》
作為副主編編寫《精神分裂症》（趙靖平主編，人民衛生出版社2012年出版）
《實用臨床精神醫學》等專業精神科著作
參與編寫《中國失眠防治指南》（人民衛生出版社2012，楊甫德、陳彥方主編）等5部專業精神科參考書。
代表論文
1, Zheng Y（鄭英君）, Watakabe A, Takada M, Kakita A, Namba H, Takahashi H, Yamamori T, Nawa H. expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):701-6.
2，Zheng Y（鄭英君）, Sudou K, Nawa H, Namba H. Field potential recording in the ventral tegmental area: pharmacological and toxicological evaluations of postsynaptic dopaminergic neuron activity. Neurosci Res. 2006 Aug;55(4):426-33.
3，Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, Zheng Y（鄭英君）, Eda T, Nawa H.A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. J Neurosci. 2007 Sep 19;27(38):10116-27.
4, Namba H, Zheng Y（鄭英君）, Abe Y, Nawa H.Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice. Neuroscience. 2009 Feb 18;158(4):1731-41.
5, Abe Y, Namba H, Zheng Y（鄭英君）, Nawa H. Neuroscience. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. 2009 Jun 16;161(1):95-110.
6, Tohmi M, Tsuda N, Zheng Y(鄭英君), Mizuno M, Sotoyama H, Shibuya M, Kawamura M, Kakita A, Takahashi H, Nawa H.The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy. Neuroscience. 2007 Nov 30;150(1):234-50.
7. Sotoyama H, Zheng Y, Iwakura Y, Mizuno M, Aizawa M, Shcherbakova K, Wang R, Namba H, Nawa H. Pallidal hyperdopaminergic innervation underlying d2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. PLoS One. 2011;6(10)
8. Iwakura Y, Zheng Y（鄭英君), Sibilia M, Abe Y, Piao YS, Yokomaku D, Wang R, Ishizuka Y, Takei N, Nawa H. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). J Neurochem. 2011 Jul;118(1):45-56.
9.Mizuno M, Iwakura Y, Shibuya M, Zheng Y（鄭英君), Eda T, Kato T, Takasu Y, Nawa H. Antipsychotic potential of quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning. J Pharmacol Sci. 2010;114(3):320-31. Epub 2010 Oct 14.
10. Ryufuku M, Toyoshima Y, Kitaura H, Zheng Y（鄭英君), Fu YJ, Miyahara H, Murakami H, Masuda H, Kameyama S, Takahashi H, Kakita A. Hypertrophy of hippocampal end folium neurons in patients with mesial temporal lobe epilepsy.
Neuropathology. 2011 Oct;31(5):476-85.
11. Hu M, Chen J, Li L, Zheng Y（鄭英君), Wang J, Guo X, Wu R, Zhao J. Semantic fluency and executive functions as candidate endophenotypes for the early diagnosis of schizophrenia in Han Chinese. Neurosci Lett. 2011 Sep 20;502(3):173-7.
